Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Fruehauf

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Blood|November 9, 2002
Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cellsStephanie Laufs, Bernhard Gentner, K Zsuzsanna Nagy, et al.
Onkologie|October 12, 2011
A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasionDoreen Heckmann, Stephanie Laufs, Patrick Maier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2013
The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancerDoreen Heckmann, Patrick Maier, Stephanie Laufs, et al.
Cytotherapy|November 26, 2009
A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II studyStefan Fruehauf, Marlon Romano Veldwijk, Timon Seeger, et al.
Cancer|March 7, 2007
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisisStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
The Journal of Gene Medicine|September 9, 2006
Lentiviral vector integration sites in human NOD/SCID repopulating cellsStephanie Laufs, Guillermo Guenechea, Africa Gonzalez-Murillo, et al.
European Journal of Haematology|October 18, 2006
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantationJens Klaus, Doris Herrmann, Iris Breitkreutz, et al.
Experimental Hematology|July 26, 2006
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristicsStefan Fruehauf, Timon Seeger, Patrick Maier, et al.
Human Gene Therapy|February 16, 2011
Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapyFrank A Giordano, Ursula R Sorg, Jens-Uwe Appelt, et al.
European Journal of Haematology|December 14, 2005
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre studyMartin Bornhäuser, Nicolaus Kröger, Rainer Schwerdtfeger, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Blood|November 9, 2002
Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cellsStephanie Laufs, Bernhard Gentner, K Zsuzsanna Nagy, et al.
Onkologie|October 12, 2011
A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasionDoreen Heckmann, Stephanie Laufs, Patrick Maier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2013
The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancerDoreen Heckmann, Patrick Maier, Stephanie Laufs, et al.
Cytotherapy|November 26, 2009
A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II studyStefan Fruehauf, Marlon Romano Veldwijk, Timon Seeger, et al.
Cancer|March 7, 2007
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisisStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
The Journal of Gene Medicine|September 9, 2006
Lentiviral vector integration sites in human NOD/SCID repopulating cellsStephanie Laufs, Guillermo Guenechea, Africa Gonzalez-Murillo, et al.
European Journal of Haematology|October 18, 2006
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantationJens Klaus, Doris Herrmann, Iris Breitkreutz, et al.
Experimental Hematology|July 26, 2006
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristicsStefan Fruehauf, Timon Seeger, Patrick Maier, et al.
Human Gene Therapy|February 16, 2011
Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapyFrank A Giordano, Ursula R Sorg, Jens-Uwe Appelt, et al.
European Journal of Haematology|December 14, 2005
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre studyMartin Bornhäuser, Nicolaus Kröger, Rainer Schwerdtfeger, et al.
Pageof 7